BioCentury | Feb 2, 2021
Politics, Policy & Law

Biopharma execs push back on Rep. Porter’s push to rein in M&A

Rep. Katie Porter (D-Calif.), a rising voice in the progressive wing of the Democratic Party, has released a report that portrays biopharma mergers and acquisitions as harmful to innovation and recommends laws that would slow...
BioCentury | Sep 30, 2020
Product Development

Ovid looks to broad path forward for rare epilepsy program

...Tokyo:4502; NYSE:TAK) share the costs and profits from the soticlestat program 50/50 (see “Marriage of Minds”; “Ovid Spreads its Wings”). Elsewhere...
BioCentury | Sep 30, 2020
Politics, Policy & Law

Former FDA leaders call out White House for undermining FDA

...Alex Azar that appears to clip the wings...
BioCentury | Sep 19, 2020
Politics, Policy & Law

Azar clips wings of FDA, CDC, NIH and other health agencies

In a move that former government officials are interpreting as a power grab that could signal a reduction in the ability of public health agencies to act independently, HHS Secretary Alex Azar has revoked the...
BioCentury | Sep 17, 2020
Product Development

Sept. 16 Quick Takes: AAT deficiency data lift Arrowhead; plus Metacrine’s IPO, Seer spinout and PDUFA dates for Niemann-Pick, burn therapies

Arrowhead gains on AAT deficiency dataArrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) gained nearly $1.4 billion in market cap Wednesday after sharing interim data from four alpha-antitrypsin (AAT) deficiency patients treated with ARO-AAT in the Phase II AROAAT2002...
BioCentury | Jul 23, 2020
Emerging Company Profile

On track for 2021 launch, Seer unveils unbiased proteomics tech and latest $55M round

With a fresh $55 million and a new publication detailing its nanoparticle-based technology, Seer thinks it can bring the scale and speed of next-generation sequencing to proteomics next year. On Wednesday, Seer announced a series...
BioCentury | Jul 16, 2020
Finance

Relay’s IPO among the year’s largest for a biotech as others wait in wings

In a year when most new biotech listings have surpassed expectations, Relay’s upsized $400 million IPO is the second-largest yet for a therapeutics developer in 2020. The clinical developer of precision oncology therapies posted a...
BioCentury | Jul 10, 2020
Finance

After pouring into biotech in 2Q, will generalists stay or will they go?

Investors believe generalists are likely to remain overweight in healthcare until there’s confidence that the broader economy can start to recover. When that will happen and whether some generalists might stick around even after recovery...
BioCentury | May 23, 2020
Emerging Company Profile

Praxis: connecting the neurological dots

...GABA diffusing out of the synapse and binding the extrasynaptic receptors (see “Ovid Spreads its Wings”...
BioCentury | May 16, 2020
Management Tracks

Management Tracks: Evox, Phoenix Tissue Repair, Artax, Nucleix, IsoPlexis, Centogene, Immunicum, CohBar and CorMedix

...and CEO at Valerion Therapeutics LLC and Wings Therapeutics. Landy is CMO at Valerion and Wings...
Items per page:
1 - 10 of 96
BioCentury | Feb 2, 2021
Politics, Policy & Law

Biopharma execs push back on Rep. Porter’s push to rein in M&A

Rep. Katie Porter (D-Calif.), a rising voice in the progressive wing of the Democratic Party, has released a report that portrays biopharma mergers and acquisitions as harmful to innovation and recommends laws that would slow...
BioCentury | Sep 30, 2020
Product Development

Ovid looks to broad path forward for rare epilepsy program

...Tokyo:4502; NYSE:TAK) share the costs and profits from the soticlestat program 50/50 (see “Marriage of Minds”; “Ovid Spreads its Wings”). Elsewhere...
BioCentury | Sep 30, 2020
Politics, Policy & Law

Former FDA leaders call out White House for undermining FDA

...Alex Azar that appears to clip the wings...
BioCentury | Sep 19, 2020
Politics, Policy & Law

Azar clips wings of FDA, CDC, NIH and other health agencies

In a move that former government officials are interpreting as a power grab that could signal a reduction in the ability of public health agencies to act independently, HHS Secretary Alex Azar has revoked the...
BioCentury | Sep 17, 2020
Product Development

Sept. 16 Quick Takes: AAT deficiency data lift Arrowhead; plus Metacrine’s IPO, Seer spinout and PDUFA dates for Niemann-Pick, burn therapies

Arrowhead gains on AAT deficiency dataArrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) gained nearly $1.4 billion in market cap Wednesday after sharing interim data from four alpha-antitrypsin (AAT) deficiency patients treated with ARO-AAT in the Phase II AROAAT2002...
BioCentury | Jul 23, 2020
Emerging Company Profile

On track for 2021 launch, Seer unveils unbiased proteomics tech and latest $55M round

With a fresh $55 million and a new publication detailing its nanoparticle-based technology, Seer thinks it can bring the scale and speed of next-generation sequencing to proteomics next year. On Wednesday, Seer announced a series...
BioCentury | Jul 16, 2020
Finance

Relay’s IPO among the year’s largest for a biotech as others wait in wings

In a year when most new biotech listings have surpassed expectations, Relay’s upsized $400 million IPO is the second-largest yet for a therapeutics developer in 2020. The clinical developer of precision oncology therapies posted a...
BioCentury | Jul 10, 2020
Finance

After pouring into biotech in 2Q, will generalists stay or will they go?

Investors believe generalists are likely to remain overweight in healthcare until there’s confidence that the broader economy can start to recover. When that will happen and whether some generalists might stick around even after recovery...
BioCentury | May 23, 2020
Emerging Company Profile

Praxis: connecting the neurological dots

...GABA diffusing out of the synapse and binding the extrasynaptic receptors (see “Ovid Spreads its Wings”...
BioCentury | May 16, 2020
Management Tracks

Management Tracks: Evox, Phoenix Tissue Repair, Artax, Nucleix, IsoPlexis, Centogene, Immunicum, CohBar and CorMedix

...and CEO at Valerion Therapeutics LLC and Wings Therapeutics. Landy is CMO at Valerion and Wings...
Items per page:
1 - 10 of 96